[ad_1]
Goldman Sachs downgraded Diageo from a neutral rating as its analysts predicted a slump in the U.S. spirits market will have an outsized impact on its sales
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...